PAM
GBIO

Panagora Asset Management’s Generation Bio GBIO Stock Holding History

Panagora Asset Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,637
Closed -$35K – 1148
2025
Q1 		$35K Sell
8,637
-127
-1% -$892 ﹤0.01% 1094
2024
Q4 		$92.9K Buy
8,764
+11
+0.1% +$196 ﹤0.01% 1117
2024
Q3 		$216K Sell
8,753
-9
-0.1% -$238 ﹤0.01% 1128
2024
Q2 		$247K Sell
8,762
-32
-0.4% -$1.04K ﹤0.01% 1088
2024
Q1 		$358K Buy
8,794
+5,830
+197% +$137K ﹤0.01% 1041
2023
Q4 		$48.9K Buy
+2,964
New +$51.7K ﹤0.01% 1213
2023
Q1 		– Sell
-5,861
Closed -$230K – 1479
2022
Q4 		$230K Buy
+5,861
New +$308K ﹤0.01% 1347

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return